Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway

doi:10.1038/s41401-021-00678-5

KIB OpenIR

	Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway
	Li,Xu-xia ; Zhang,Peng ; Yang,Yang; Wang,Jing-jing ; Zheng,Yan-jun ; Tan,Ji-liang ; Liu,Shen-yan ; Yan,Yong-ming ; Zhang,You-yi ; Cheng,Yong-xian ; Yang,Huang-tian
	2022
发表期刊	ACTA PHARMACOLOGICA SINICA
ISSN	1671-4083
卷号	43 期号:3 页码:588-601
摘要	Cardiac hypertrophy is a common adaptive response to a variety of stimuli, but prolonged hypertrophy leads to heart failure. Hence, discovery of agents treating cardiac hypertrophy is urgently needed. In the present study, we investigated the effects of QF84139, a newly synthesized pyrazine derivative, on cardiac hypertrophy and the underlying mechanisms. In neonatal rat cardiomyocytes (NRCMs), pretreatment with QF84139 (1-10 mu M) concentration-dependently inhibited phenylephrine-induced hypertrophic responses characterized by fetal genes reactivation, increased ANP protein level and enlarged cardiomyocytes. In adult male mice, administration of QF84139 (5-90 mg center dot kg(-1)center dot d(-1), i.p., for 2 weeks) dose-dependently reversed transverse aortic constriction (TAC)-induced cardiac hypertrophy displayed by cardiomyocyte size, left ventricular mass, heart weights, and reactivation of fetal genes. We further revealed that QF84139 selectively activated the AMPK signaling pathway without affecting the phosphorylation of CaMKII delta, ERK1/2, AKT, PKC epsilon, and P38 kinases in phenylephrine-treated NRCMs and in the hearts of TAC-treated mice. In NRCMs, QF84139 did not show additive effects with metformin on the AMPK activation, whereas the anti-hypertrophic effect of QF84139 was abolished by an AMPK inhibitor Compound C or knockdown of AMPK alpha 2. In AMPK alpha 2-deficient mice, the anti-hypertrophic effect of QF84139 was also vanished. These results demonstrate that QF84139 attenuates the PE- and TAC-induced cardiac hypertrophy via activating the AMPK signaling. This structurally novel compound would be a promising lead compound for developing effective agents for the treatment of cardiac hypertrophy.
关键词	cardiac hypertrophy pyrazine derivative QF84139 phenylephrine transverse aortic constriction AMPK signaling pathway PROTEIN-KINASE MAMMALIAN TARGET OVERLOAD METFORMIN MACROPHAGES MECHANISMS MEDICINE ALPHA CELLS MODEL
DOI	10.1038/s41401-021-00678-5
收录类别	SCI
WOS记录号	WOS:000648507200001
引用统计
文献类型	期刊论文
条目标识符	http://ir.kib.ac.cn/handle/151853/73161
专题	中国科学院昆明植物研究所
作者单位	1.[Li, Xu-xia 2.Zhang, Peng 3.Zheng, Yan-jun 4.Tan, Ji-liang 5.Liu, Shen-yan 6.Chinese Acad Sci, Univ Chinese Acad Sci, CAS Key Lab Tissue Microenvironm & Tumor, Lab Mol Cardiol,Shanghai Inst Nutr & Hlth, Shanghai 200031, Peoples R China 7.[Yang, Yang 8.Yan, Yong-ming 9.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China 10.[Wang, Jing-jing 11.Peking Univ Third Hosp, Dept Cardiol, Beijing 100191, Peoples R China 12.Peking Univ Third Hosp, Inst Vasc Med, Beijing 100191, Peoples R China 13.NHC Key Lab Cardiovasc Mol Biol & Regulatory Pept, Beijing 100191, Peoples R China 14.Minist Educ, Beijing Key Lab Cardiovasc Receptors Res, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China 15.Shenzhen Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Shenzhen 518060, Peoples R China 16.Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Cardiol, Shanghai 200233, Peoples R China 17.Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China
推荐引用方式 GB/T 7714	Li,Xu-xia,Zhang,Peng,Yang,Yang,et al. Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway[J]. ACTA PHARMACOLOGICA SINICA,2022,43(3):588-601.
APA	Li,Xu-xia.,Zhang,Peng.,Yang,Yang.,Wang,Jing-jing.,Zheng,Yan-jun.,...&Yang,Huang-tian.(2022).Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway.ACTA PHARMACOLOGICA SINICA,43(3),588-601.
MLA	Li,Xu-xia,et al."Small molecule QF84139 ameliorates cardiac hypertrophy via activating the AMPK signaling pathway".ACTA PHARMACOLOGICA SINICA 43.3(2022):588-601.

条目包含的文件		下载所有文件
文件名称/大小	文献类型	版本类型	开放类型	使用许可
10.1038_s41401-021-0（4052KB）	期刊论文	出版稿	开放获取	CC BY-NC-SA	浏览下载